BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17086519)

  • 1. Transcatheter closure of perimembranous ventricular septal defects using umbrella devices.
    Handke R; Jux C; Schranz D; Schneider M
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):936-41. PubMed ID: 17086519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
    Carminati M; Butera G; Chessa M; Drago M; Negura D; Piazza L
    Am J Cardiol; 2005 Dec; 96(12A):52L-58L. PubMed ID: 16399093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter closure of congenital muscular ventricular septal defect.
    Arora R; Trehan V; Thakur AK; Mehta V; Sengupta PP; Nigam M
    J Interv Cardiol; 2004 Apr; 17(2):109-15. PubMed ID: 15104774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience.
    Szkutnik M; Kusa J; Białkowski J
    Kardiol Pol; 2008 Sep; 66(9):941-7; discussion 948-9. PubMed ID: 18924021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter closure of muscular ventricular septal defect using the Amplatzer devices.
    Djer MM; Latiff HA; Alwi M; Samion H; Kandavello G
    Heart Lung Circ; 2006 Feb; 15(1):12-7. PubMed ID: 16473785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter closure of postoperative residual perimembranous ventricular septal defects.
    Gu MB; Bai Y; Zhao XX; Zheng X; Li WP; Qin YW
    Ann Thorac Surg; 2009 Nov; 88(5):1551-5. PubMed ID: 19853111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device.
    Chessa M; Carminati M; Cao QL; Butera G; Giusti S; Bini RM; Hijazi ZM
    J Invasive Cardiol; 2002 Jun; 14(6):322-7. PubMed ID: 12042624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device.
    Bass JL; Kalra GS; Arora R; Masura J; Gavora P; Thanopoulos BD; Torres W; Sievert H; Carminati M; Fischer G; Ewert P
    Catheter Cardiovasc Interv; 2003 Feb; 58(2):238-45. PubMed ID: 12552550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial.
    Fu YC; Bass J; Amin Z; Radtke W; Cheatham JP; Hellenbrand WE; Balzer D; Cao QL; Hijazi ZM
    J Am Coll Cardiol; 2006 Jan; 47(2):319-25. PubMed ID: 16412854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for arrhythmia early after transcatheter closure of perimembranous ventricular septal defects].
    Sun XJ; Gao W; Zhou AQ; Yu ZQ; Li F; Huang MR; Sun K
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):767-71. PubMed ID: 16255857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology Insight: transcatheter closure of ventricular septal defects.
    Moodie DS
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):592-6. PubMed ID: 16258571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias.
    Wilson NJ; Smith J; Prommete B; O'Donnell C; Gentles TL; Ruygrok PN
    Heart Lung Circ; 2008 Aug; 17(4):318-24. PubMed ID: 18407789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device closure of congenital ventricular septal defects with Amplatzer devices: first experiences in Turkey.
    Celiker A; Ozkutlu S; Karagöz T; Erdoğan I; Ozer S; Aypar E
    Turk J Pediatr; 2008; 50(2):106-13. PubMed ID: 18664072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter closure of congenital ventricular septal defects: results of the European Registry.
    Carminati M; Butera G; Chessa M; De Giovanni J; Fisher G; Gewillig M; Peuster M; Piechaud JF; Santoro G; Sievert H; Spadoni I; Walsh K;
    Eur Heart J; 2007 Oct; 28(19):2361-8. PubMed ID: 17684082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up.
    El Said HG; Bratincsak A; Gordon BM; Moore JW
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):895-903. PubMed ID: 22907908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate primary transcatheter closure of postinfarction ventricular septal defects.
    Thiele H; Kaulfersch C; Daehnert I; Schoenauer M; Eitel I; Borger M; Schuler G
    Eur Heart J; 2009 Jan; 30(1):81-8. PubMed ID: 19036747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter closure of congenital perimembranous ventricular septal defect in children using symmetric occluders: an 8-year multiinstitutional experience.
    Wang L; Cao S; Li J; Yang L; Liu Y; Ren J; Ma Q; Xing H; Li D; Tian D; Wan Y; Yu S; Chen T; Yang X; Yang J
    Ann Thorac Surg; 2012 Aug; 94(2):592-8. PubMed ID: 22626754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete heart block associated with device closure of perimembranous ventricular septal defects.
    Predescu D; Chaturvedi RR; Friedberg MK; Benson LN; Ozawa A; Lee KJ
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1223-8. PubMed ID: 19026807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre.
    Kenny D; Morgan G; Bajwa A; Farrow C; Parry A; Caputo M; Tometzki A; Martin R
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):568-75. PubMed ID: 19235245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrograde use of the Cardioseal/Starflex occluder device.
    Jux C; Schneider M; Paul T
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):448-54. PubMed ID: 15926174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.